Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Sales reflect continued strong growth in oncology and vaccines
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Subscribe To Our Newsletter & Stay Updated
